COUNTERVEW CAPITAL MANAGEMENT

Counterview runs a concentrated, fundamental long-short equity strategy with a defining emphasis on forensic accounting. The long book targets undervalued quality businesses, while the short book consists of high-conviction bets against companies the firm believes are misrepresenting their financial condition. The strategy operates with low net exposure, seeking to generate alpha from stock selection rather than market direction.

The firm sources short ideas through proprietary forensic accounting research. Analysts scrutinize SEC filings, corporate registries, supplier networks, and customer contracts to identify discrepancies between reported financials and economic reality. This investigative process is the core engine of the firm, and positions are sized according to the conviction level of the research findings, not passive risk-model inputs.

No. Counterview maintains a deliberately low public profile and does not publish its investigative research externally. This contrasts with activist short-sellers who release detailed reports to move stock prices. The firm's discretion protects the integrity of its research process and reduces the legal and reputational risk of engaging with target companies.

Counterview operates as an asset manager structured around a pooled long-short equity fund rather than a single-family office. It manages capital for external investors alongside any internal partner capital, though the firm provides no public detail on its investor base or fund structure. The operational model is consistent with a classic hedge fund partnership, not a family office managing a single fortune.

Counterview does not publicly report performance, and no third-party databases carry verified returns data for the firm. The forensic-equity sub-strategy produces lumpy, idiosyncratic returns that do not track broad equity indexes, and investors must rely on direct due diligence to assess the firm's track record. This opacity is common among managers whose edge depends on maintaining confidentiality around ongoing research positions.